Frueh FW - Search Results

1

Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study.

Kreutz RP, Stanek EJ, Aubert R, Yao J, Breall JA, Desta Z, Skaar TC, Teagarden JR, Frueh FW, Epstein RS, Flockhart DA. Kreutz RP, et al. Among authors: frueh fw. Pharmacotherapy. 2010 Aug;30(8):787-96. doi: 10.1592/phco.30.8.787. Pharmacotherapy. 2010. PMID: 20653354

2

Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.

Frueh FW, Amur S, Mummaneni P, Epstein RS, Aubert RE, DeLuca TM, Verbrugge RR, Burckart GJ, Lesko LJ. Frueh FW, et al. Pharmacotherapy. 2008 Aug;28(8):992-8. doi: 10.1592/phco.28.8.992. Pharmacotherapy. 2008. PMID: 18657016

3

Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information.

Stanek EJ, Sanders CL, Frueh FW. Stanek EJ, et al. Among authors: frueh fw. J Pers Med. 2013 Jun 10;3(2):111-23. doi: 10.3390/jpm3020111. J Pers Med. 2013. PMID: 25562522 Free PMC article.

4

Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.

Stanek EJ, Sanders CL, Taber KA, Khalid M, Patel A, Verbrugge RR, Agatep BC, Aubert RE, Epstein RS, Frueh FW. Stanek EJ, et al. Among authors: frueh fw. Clin Pharmacol Ther. 2012 Mar;91(3):450-8. doi: 10.1038/clpt.2011.306. Epub 2012 Jan 25. Clin Pharmacol Ther. 2012. PMID: 22278335

5

Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial.

Charland SL, Agatep BC, Herrera V, Schrader B, Frueh FW, Ryvkin M, Shabbeer J, Devlin JJ, Superko HR, Stanek EJ. Charland SL, et al. Among authors: frueh fw. Pharmacogenomics J. 2014 Jun;14(3):272-80. doi: 10.1038/tpj.2013.27. Epub 2013 Aug 27. Pharmacogenomics J. 2014. PMID: 23979174

6

Payer perspectives on pharmacogenomics testing and drug development.

Epstein RS, Frueh FW, Geren D, Hummer D, McKibbin S, O'Connor S, Randhawa G, Zelman B. Epstein RS, et al. Among authors: frueh fw. Pharmacogenomics. 2009 Jan;10(1):149-51. doi: 10.2217/14622416.10.1.149. Pharmacogenomics. 2009. PMID: 19102724

7

Integration and use of biomarkers in drug development, regulation and clinical practice: a US regulatory perspective.

Amur S, Frueh FW, Lesko LJ, Huang SM. Amur S, et al. Among authors: frueh fw. Biomark Med. 2008 Jun;2(3):305-11. doi: 10.2217/17520363.2.3.305. Biomark Med. 2008. PMID: 20477416

8

Application of pharmacogenomics in clinical pharmacology.

Huang SM, Goodsaid F, Rahman A, Frueh F, Lesko LJ. Huang SM, et al. Toxicol Mech Methods. 2006;16(2-3):89-99. doi: 10.1080/15376520600558333. Toxicol Mech Methods. 2006. PMID: 20021001

9

The experience with voluntary genomic data submissions at the FDA and a vision for the future of the voluntary data submission program.

Orr MS, Goodsaid F, Amur S, Rudman A, Frueh FW. Orr MS, et al. Among authors: frueh fw. Clin Pharmacol Ther. 2007 Feb;81(2):294-7. doi: 10.1038/sj.clpt.6100053. Clin Pharmacol Ther. 2007. PMID: 17259954 Review.

10

Qualification of biomarkers for drug development in organ transplantation.

Burckart GJ, Amur S, Goodsaid FM, Lesko LJ, Frueh FW, Huang SM, Cavaille-Coll MW. Burckart GJ, et al. Among authors: frueh fw. Am J Transplant. 2008 Feb;8(2):267-70. doi: 10.1111/j.1600-6143.2007.02063.x. Epub 2007 Dec 18. Am J Transplant. 2008. PMID: 18093264 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters